Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage

Dong Wan Kang, Chi Kyung Kim, Han Gil Jeong, Min Soh, Taeho Kim, In Young Choi, Seul Ki Ki, Do Yeon Kim, Wookjin Yang, Taeghwan Hyeon, Seung Hoon Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4% as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH. [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)2743-2760
Number of pages18
JournalNano Research
Volume10
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Cerium compounds
Reactive Oxygen Species
Nanoparticles
Oxygen
Oxidative stress
Hemin
Free Radical Scavengers
Macrophages
Phospholipids
Micelles
Cytotoxicity
Free radicals
Biocompatibility
Polyethylene glycols
Deterioration
Brain
Proteins

Keywords

  • anti-inflammation
  • biomedical application
  • ceria nanoparticles
  • free radical injury
  • intracerebral hemorrhage
  • neuroprotective agents

ASJC Scopus subject areas

  • Materials Science(all)
  • Electrical and Electronic Engineering

Cite this

Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage. / Kang, Dong Wan; Kim, Chi Kyung; Jeong, Han Gil; Soh, Min; Kim, Taeho; Choi, In Young; Ki, Seul Ki; Kim, Do Yeon; Yang, Wookjin; Hyeon, Taeghwan; Lee, Seung Hoon.

In: Nano Research, Vol. 10, No. 8, 01.08.2017, p. 2743-2760.

Research output: Contribution to journalArticle

Kang, DW, Kim, CK, Jeong, HG, Soh, M, Kim, T, Choi, IY, Ki, SK, Kim, DY, Yang, W, Hyeon, T & Lee, SH 2017, 'Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage', Nano Research, vol. 10, no. 8, pp. 2743-2760. https://doi.org/10.1007/s12274-017-1478-6
Kang, Dong Wan ; Kim, Chi Kyung ; Jeong, Han Gil ; Soh, Min ; Kim, Taeho ; Choi, In Young ; Ki, Seul Ki ; Kim, Do Yeon ; Yang, Wookjin ; Hyeon, Taeghwan ; Lee, Seung Hoon. / Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage. In: Nano Research. 2017 ; Vol. 10, No. 8. pp. 2743-2760.
@article{90d96821062842a2ae8729460b5f179d,
title = "Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage",
abstract = "Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4{\%} as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH. [Figure not available: see fulltext.].",
keywords = "anti-inflammation, biomedical application, ceria nanoparticles, free radical injury, intracerebral hemorrhage, neuroprotective agents",
author = "Kang, {Dong Wan} and Kim, {Chi Kyung} and Jeong, {Han Gil} and Min Soh and Taeho Kim and Choi, {In Young} and Ki, {Seul Ki} and Kim, {Do Yeon} and Wookjin Yang and Taeghwan Hyeon and Lee, {Seung Hoon}",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s12274-017-1478-6",
language = "English",
volume = "10",
pages = "2743--2760",
journal = "Nano Research",
issn = "1998-0124",
publisher = "Press of Tsinghua University",
number = "8",

}

TY - JOUR

T1 - Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage

AU - Kang, Dong Wan

AU - Kim, Chi Kyung

AU - Jeong, Han Gil

AU - Soh, Min

AU - Kim, Taeho

AU - Choi, In Young

AU - Ki, Seul Ki

AU - Kim, Do Yeon

AU - Yang, Wookjin

AU - Hyeon, Taeghwan

AU - Lee, Seung Hoon

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4% as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH. [Figure not available: see fulltext.].

AB - Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4% as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH. [Figure not available: see fulltext.].

KW - anti-inflammation

KW - biomedical application

KW - ceria nanoparticles

KW - free radical injury

KW - intracerebral hemorrhage

KW - neuroprotective agents

UR - http://www.scopus.com/inward/record.url?scp=85017586114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017586114&partnerID=8YFLogxK

U2 - 10.1007/s12274-017-1478-6

DO - 10.1007/s12274-017-1478-6

M3 - Article

AN - SCOPUS:85017586114

VL - 10

SP - 2743

EP - 2760

JO - Nano Research

JF - Nano Research

SN - 1998-0124

IS - 8

ER -